Defective Osteoclastogenesis by IKKβ-null Precursors Is a Result of Receptor Activator of NF-κB Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation
Jesse E. Otero(OrthoCarolina), Yousef Abu‐Amer(Washington University in St. Louis)
Cited by 52
Related Papers
Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies
|Arthritis Research & Therapy|2007|526
Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways
|Journal of Biological Chemistry|2001|499
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
|Nature Communications|2020|386
IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB
|Journal of Clinical Investigation|2001|188